Cancer immunotherapy drug ‘less toxic and prolongs life’
- Saturday, November 23, 2019, 5:58
- Health, Sports
- Add a comment
Pembrolizumab held advanced head and neck cancers in a group of patients at bay for around two years.
About the Author
adminasapcorp has written 41866 stories on this site.